Cartiva
Acquired
- Headquarters
- Atlanta, Georgia
- Employees
- 11–50
- Founded
- 2013
- Business Model
- B2B
- Website
- cartiva.net
- Total Funding
- $8.5M
- Last Round
- $8.5M Series DMay 2015
About
Cartiva developed the Synthetic Cartilage Implant (SCI), the first and only FDA-approved synthetic cartilage device for treating osteoarthritis of the first metatarsophalangeal (big toe) joint. The SCI is composed of a biocompatible polyvinyl alcohol hydrogel polymer with mechanical properties mimicking natural articular cartilage, implantable in approximately 35 minutes. The company was acquired by Wright Medical Group N.V. in October 2018 for $435 million, and subsequently became part of Stryker following Stryker's acquisition of Wright Medical in 2020.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account